Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Formulas/Products
Skin Care
Multimedia
News
Regulations
Research
Testing
Enter search phrase
Search
58 Results
Type: News
Section: Formulas/Products > Skin Care
Claims/Labeling
FDA Hones in on Cosmetic Claims
The FDA issued five such letters since November 2014, the most recent being sent to StriVectin. Following those letters, the FDA has also issued a document that clarifies cosmetic versus drug claims for the consumer to highlight what cosmetic companies are able to say.
Claims/Labeling
FDA Cracks Down on Skin Lighteners
Skin whitening products walk the line between cosmetics and drugs, and often carry dangerous side effects. Flawless Beauty's injectable whitening products were struck down by a federal judge, putting lightening products under the lens.
Tech Transfer
Prescription Polymer Nail Treatment Approved by the FDA
The U.S. Food and Drug Administration (FDA) has approved a prescription polymer treatment for brittle nail symdrome (nail dystrophy).
Claims/Labeling
FDA Issues Final Guidance on Nanomaterials
On June 26, 2014, The U.S. Food and Drug Administration (FDA) issued Final Guidance for Industry: Safety of Nanomaterials in Cosmetics, a final guidance document addressing the use of nanotechnology in cosmetics.
Regional
FDA Alert: New J&J Baby Powder Recall
According to the FDA, a test sample from one lot was found to contain chrysotile fibers, a type of asbestos. As such, Oct. 18, 2019, Johnson & Johnson voluntarily recalled the product.
Actives
Antibacterial Soap? You Can Skip It, Says FDA
The FDA is issuing a final rule under which OTC consumer antiseptic wash products containing the majority of the antibacterial active ingredients—including triclosan and triclocarban—will no longer be able to be marketed.
Regional
FDA Sets Regulatory Framework for Regenerative Biological Therapies
It's a sign of the times when technology and innovation hit a point where the U.S. Food and Drug Administration must stop and write new rules to ensure consumer safety. That time, with respect to regenerative biological therapies, is now.
Regional
FDA Publishes its Draft Guidance for Cosmetic GMPs
The U.S. Food and Drug Administration (FDA) has published its Draft Guidance for Cosmetic Good Manufacturing Practices (GMPs), an update to its Cosmetic Good Manufacturing Guidelines/Inspection Checklist, mostly to include ISO 227 16:2007 as part of an effort to harmonize GMPs internationally.
Skin Care
UPDATED: FDA Bans 24 Antiseptic Ingredients Including Triclosan
Along with triclosan, the FDA has banned 23 other ingredients used in health care antiseptics, finding their safety and efficacy insufficient.
Tech Transfer
FDA Clears Isoprenylcysteine Analog for Rosacea Treatment
A isoprenylcysteine (IPC) analog manufactured by biopharmaceutical company Signum Dermalogix Inc. (Dermalogix) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of rosacea.
Regional
Chinese Hand Sanitizers Make FDA's Growing Hot List
Recent additions to the U.S. Food and Drug Administration's hand sanitizer "hot list" include several products from China, Mexico and Korea.
Regional
FDA Flags Eskbiochem Hand Sanitizers for Possible Methanol Content
The U.S. Food and Drug Administration has issued a warning statement to consumers over the use of Eskbiochem's hand sanitizers, which may contain methanol, i.e., wood alcohol.
Regional
FDA Warns 1,500 New Sanitizer Makers: Follow the Rules
Safety and fraudulent claims are new concerns in the hand sanitizer market. Since the U.S. Food and Drug Administration (FDA) eased restrictions, some 1,500 new hand sanitizer manufacturers have registered to help; but many are not following the FDA's policy.
Regional
FDA Issues More Sanitizer Warnings, Posts Microbe-related Recalls
Sanitizer warning letters and "hotlist" additions, plus microbe-related recalls are among the latest cosmetic-relevant updates from the U.S. Food and Drug Administration.
Regional
U.S. FDA Investigates
B. cepacian
Complex Outbreak Linked to Personal Care
A no-rinse foam cleanser has been linked to at least 10 confirmed cases of
Burkholderia cepacia
complex; Shadow Holdings dba Bocchi Laboratories has voluntarily recalled the product as the FDA investigates.
Actives
FDA Flags 13 More Sanitizers, Issues One Warning for Methanol Content
Methanol content or possible associations therewith account for 12 of the 13 latest additions by the U.S. Food and Drug Administration (FDA) to its "do not use" hand sanitizer list, along with one warning letter.
Safety
Benzene, Methanol and Lead Headline Recent Class Actions and FDA Alerts
Methanol in hand sanitizers and lead in a baby skin care are cited in the latest U.S. Food and Drug Administration recall notices, while benzene content in dry shampoo and spray sunscreens persists among class action suits. Following is a roundup.
Regional
FDA Warns Consumers About Side Effects from Topical Acne Actives
The U.S. Food and Drug Administration has issued a warning to consumers that over-the-counter (OTC) acne products containing benzoyl peroxide and salicylic acid can cause severe irritation or severe allergic reactions in rare instances.
Page 1 of 4
Next Page